nodes	percent_of_prediction	percent_of_DWPC	metapath
Levocabastine—Eye redness—Gefitinib—lung cancer	0.0725	0.116	CcSEcCtD
Levocabastine—Ocular hyperaemia—Gefitinib—lung cancer	0.0351	0.056	CcSEcCtD
Levocabastine—Lacrimation increased—Pemetrexed—lung cancer	0.018	0.0287	CcSEcCtD
Levocabastine—Visual disturbance—Crizotinib—lung cancer	0.0139	0.0221	CcSEcCtD
Levocabastine—Eye pain—Gefitinib—lung cancer	0.0132	0.0211	CcSEcCtD
Levocabastine—Lacrimation—Irinotecan—lung cancer	0.0119	0.019	CcSEcCtD
Levocabastine—Visual impairment—Crizotinib—lung cancer	0.00878	0.014	CcSEcCtD
Levocabastine—Pharyngitis—Pemetrexed—lung cancer	0.00826	0.0132	CcSEcCtD
Levocabastine—Lacrimation—Docetaxel—lung cancer	0.00825	0.0132	CcSEcCtD
Levocabastine—Lacrimation increased—Irinotecan—lung cancer	0.00762	0.0121	CcSEcCtD
Levocabastine—Erythema—Pemetrexed—lung cancer	0.00725	0.0115	CcSEcCtD
Levocabastine—Cough—Gefitinib—lung cancer	0.00628	0.01	CcSEcCtD
Levocabastine—Lacrimation increased—Paclitaxel—lung cancer	0.00621	0.0099	CcSEcCtD
Levocabastine—Dry mouth—Gefitinib—lung cancer	0.00599	0.00956	CcSEcCtD
Levocabastine—Dyspnoea—Crizotinib—lung cancer	0.00577	0.0092	CcSEcCtD
Levocabastine—Fatigue—Crizotinib—lung cancer	0.00558	0.00889	CcSEcCtD
Levocabastine—Visual disturbance—Irinotecan—lung cancer	0.00538	0.00857	CcSEcCtD
Levocabastine—Dyspnoea—Pemetrexed—lung cancer	0.00527	0.0084	CcSEcCtD
Levocabastine—Lacrimation increased—Docetaxel—lung cancer	0.00527	0.00839	CcSEcCtD
Levocabastine—Dyspnoea—Gefitinib—lung cancer	0.00524	0.00835	CcSEcCtD
Levocabastine—Lacrimation—Doxorubicin—lung cancer	0.00515	0.00821	CcSEcCtD
Levocabastine—Pharyngitis—Vinblastine—lung cancer	0.00511	0.00814	CcSEcCtD
Levocabastine—Fatigue—Pemetrexed—lung cancer	0.0051	0.00813	CcSEcCtD
Levocabastine—Fatigue—Gefitinib—lung cancer	0.00507	0.00808	CcSEcCtD
Levocabastine—Pain—Pemetrexed—lung cancer	0.00506	0.00806	CcSEcCtD
Levocabastine—Pain—Gefitinib—lung cancer	0.00502	0.00801	CcSEcCtD
Levocabastine—Pharyngitis—Topotecan—lung cancer	0.00496	0.00791	CcSEcCtD
Levocabastine—Asthenia—Crizotinib—lung cancer	0.00464	0.0074	CcSEcCtD
Levocabastine—Eye pain—Paclitaxel—lung cancer	0.0046	0.00734	CcSEcCtD
Levocabastine—Visual disturbance—Paclitaxel—lung cancer	0.00439	0.00699	CcSEcCtD
Levocabastine—Erythema—Erlotinib—lung cancer	0.0043	0.00686	CcSEcCtD
Levocabastine—Dyspnoea—Teniposide—lung cancer	0.00427	0.00681	CcSEcCtD
Levocabastine—Asthenia—Pemetrexed—lung cancer	0.00424	0.00676	CcSEcCtD
Levocabastine—Asthenia—Gefitinib—lung cancer	0.00422	0.00672	CcSEcCtD
Levocabastine—Rash—Crizotinib—lung cancer	0.00408	0.0065	CcSEcCtD
Levocabastine—Dermatitis—Crizotinib—lung cancer	0.00408	0.0065	CcSEcCtD
Levocabastine—Nausea—Crizotinib—lung cancer	0.00384	0.00613	CcSEcCtD
Levocabastine—Cough—Topotecan—lung cancer	0.0038	0.00605	CcSEcCtD
Levocabastine—Cough—Erlotinib—lung cancer	0.00376	0.00599	CcSEcCtD
Levocabastine—Stinging—Doxorubicin—lung cancer	0.00374	0.00596	CcSEcCtD
Levocabastine—Rash—Pemetrexed—lung cancer	0.00373	0.00594	CcSEcCtD
Levocabastine—Dermatitis—Pemetrexed—lung cancer	0.00373	0.00594	CcSEcCtD
Levocabastine—Erythema—Vinorelbine—lung cancer	0.00372	0.00593	CcSEcCtD
Levocabastine—Visual disturbance—Docetaxel—lung cancer	0.00372	0.00593	CcSEcCtD
Levocabastine—Rash—Gefitinib—lung cancer	0.0037	0.00591	CcSEcCtD
Levocabastine—Dermatitis—Gefitinib—lung cancer	0.0037	0.0059	CcSEcCtD
Levocabastine—Nausea—Pemetrexed—lung cancer	0.00351	0.0056	CcSEcCtD
Levocabastine—Nausea—Gefitinib—lung cancer	0.00349	0.00556	CcSEcCtD
Levocabastine—Asthenia—Teniposide—lung cancer	0.00344	0.00548	CcSEcCtD
Levocabastine—Pharyngitis—Gemcitabine—lung cancer	0.00341	0.00543	CcSEcCtD
Levocabastine—Visual impairment—Irinotecan—lung cancer	0.0034	0.00542	CcSEcCtD
Levocabastine—Lacrimation increased—Doxorubicin—lung cancer	0.00329	0.00524	CcSEcCtD
Levocabastine—Cough—Vinorelbine—lung cancer	0.00325	0.00518	CcSEcCtD
Levocabastine—Dyspnoea—Topotecan—lung cancer	0.00317	0.00505	CcSEcCtD
Levocabastine—Dyspnoea—Erlotinib—lung cancer	0.00313	0.00499	CcSEcCtD
Levocabastine—Pain—Vinblastine—lung cancer	0.00313	0.00498	CcSEcCtD
Levocabastine—Visual impairment—Cisplatin—lung cancer	0.00308	0.00492	CcSEcCtD
Levocabastine—Fatigue—Topotecan—lung cancer	0.00306	0.00488	CcSEcCtD
Levocabastine—Pain—Topotecan—lung cancer	0.00304	0.00484	CcSEcCtD
Levocabastine—Fatigue—Erlotinib—lung cancer	0.00303	0.00483	CcSEcCtD
Levocabastine—Rash—Teniposide—lung cancer	0.00302	0.00481	CcSEcCtD
Levocabastine—Dermatitis—Teniposide—lung cancer	0.00302	0.00481	CcSEcCtD
Levocabastine—Pain—Erlotinib—lung cancer	0.003	0.00479	CcSEcCtD
Levocabastine—Headache—Teniposide—lung cancer	0.003	0.00478	CcSEcCtD
Levocabastine—Erythema—Gemcitabine—lung cancer	0.00299	0.00477	CcSEcCtD
Levocabastine—Pharyngitis—Paclitaxel—lung cancer	0.00285	0.00455	CcSEcCtD
Levocabastine—Nausea—Teniposide—lung cancer	0.00285	0.00454	CcSEcCtD
Levocabastine—Erythema—Cisplatin—lung cancer	0.00279	0.00444	CcSEcCtD
Levocabastine—Visual impairment—Paclitaxel—lung cancer	0.00277	0.00442	CcSEcCtD
Levocabastine—Dyspnoea—Vinorelbine—lung cancer	0.00271	0.00432	CcSEcCtD
Levocabastine—Visual disturbance—Methotrexate—lung cancer	0.00268	0.00427	CcSEcCtD
Levocabastine—Cough—Irinotecan—lung cancer	0.00268	0.00427	CcSEcCtD
Levocabastine—Asthenia—Vinblastine—lung cancer	0.00262	0.00418	CcSEcCtD
Levocabastine—Fatigue—Vinorelbine—lung cancer	0.00262	0.00417	CcSEcCtD
Levocabastine—Cough—Gemcitabine—lung cancer	0.00261	0.00416	CcSEcCtD
Levocabastine—Pain—Vinorelbine—lung cancer	0.0026	0.00414	CcSEcCtD
Levocabastine—Asthenia—Topotecan—lung cancer	0.00255	0.00406	CcSEcCtD
Levocabastine—Asthenia—Erlotinib—lung cancer	0.00252	0.00402	CcSEcCtD
Levocabastine—Erythema—Paclitaxel—lung cancer	0.0025	0.00399	CcSEcCtD
Levocabastine—Eye pain—Doxorubicin—lung cancer	0.00244	0.00388	CcSEcCtD
Levocabastine—Pharyngitis—Docetaxel—lung cancer	0.00242	0.00386	CcSEcCtD
Levocabastine—Visual impairment—Docetaxel—lung cancer	0.00235	0.00374	CcSEcCtD
Levocabastine—Headache—Vinblastine—lung cancer	0.00229	0.00365	CcSEcCtD
Levocabastine—Rash—Topotecan—lung cancer	0.00224	0.00357	CcSEcCtD
Levocabastine—Dermatitis—Topotecan—lung cancer	0.00224	0.00356	CcSEcCtD
Levocabastine—Dyspnoea—Irinotecan—lung cancer	0.00223	0.00356	CcSEcCtD
Levocabastine—Cough—Etoposide—lung cancer	0.00223	0.00355	CcSEcCtD
Levocabastine—Somnolence—Irinotecan—lung cancer	0.00223	0.00355	CcSEcCtD
Levocabastine—Headache—Topotecan—lung cancer	0.00222	0.00355	CcSEcCtD
Levocabastine—Rash—Erlotinib—lung cancer	0.00221	0.00353	CcSEcCtD
Levocabastine—Dermatitis—Erlotinib—lung cancer	0.00221	0.00353	CcSEcCtD
Levocabastine—Headache—Erlotinib—lung cancer	0.0022	0.00351	CcSEcCtD
Levocabastine—Cough—Paclitaxel—lung cancer	0.00218	0.00348	CcSEcCtD
Levocabastine—Asthenia—Vinorelbine—lung cancer	0.00218	0.00347	CcSEcCtD
Levocabastine—Dyspnoea—Gemcitabine—lung cancer	0.00218	0.00347	CcSEcCtD
Levocabastine—Nausea—Vinblastine—lung cancer	0.00217	0.00346	CcSEcCtD
Levocabastine—Somnolence—Gemcitabine—lung cancer	0.00217	0.00346	CcSEcCtD
Levocabastine—Fatigue—Irinotecan—lung cancer	0.00216	0.00344	CcSEcCtD
Levocabastine—Pain—Irinotecan—lung cancer	0.00214	0.00341	CcSEcCtD
Levocabastine—Erythema—Docetaxel—lung cancer	0.00212	0.00338	CcSEcCtD
Levocabastine—Nausea—Topotecan—lung cancer	0.00211	0.00336	CcSEcCtD
Levocabastine—Fatigue—Gemcitabine—lung cancer	0.0021	0.00335	CcSEcCtD
Levocabastine—Pain—Gemcitabine—lung cancer	0.00209	0.00333	CcSEcCtD
Levocabastine—Nausea—Erlotinib—lung cancer	0.00209	0.00333	CcSEcCtD
Levocabastine—Dry mouth—Paclitaxel—lung cancer	0.00208	0.00332	CcSEcCtD
Levocabastine—Dyspnoea—Cisplatin—lung cancer	0.00203	0.00323	CcSEcCtD
Levocabastine—Pain—Cisplatin—lung cancer	0.00194	0.0031	CcSEcCtD
Levocabastine—Rash—Vinorelbine—lung cancer	0.00192	0.00305	CcSEcCtD
Levocabastine—Dermatitis—Vinorelbine—lung cancer	0.00191	0.00305	CcSEcCtD
Levocabastine—Headache—Vinorelbine—lung cancer	0.0019	0.00303	CcSEcCtD
Levocabastine—Dyspnoea—Etoposide—lung cancer	0.00186	0.00296	CcSEcCtD
Levocabastine—Somnolence—Etoposide—lung cancer	0.00185	0.00295	CcSEcCtD
Levocabastine—Cough—Docetaxel—lung cancer	0.00185	0.00295	CcSEcCtD
Levocabastine—Dyspnoea—Paclitaxel—lung cancer	0.00182	0.0029	CcSEcCtD
Levocabastine—Somnolence—Paclitaxel—lung cancer	0.00182	0.00289	CcSEcCtD
Levocabastine—Nausea—Vinorelbine—lung cancer	0.0018	0.00288	CcSEcCtD
Levocabastine—Asthenia—Irinotecan—lung cancer	0.0018	0.00286	CcSEcCtD
Levocabastine—Fatigue—Etoposide—lung cancer	0.0018	0.00286	CcSEcCtD
Levocabastine—Pain—Etoposide—lung cancer	0.00178	0.00284	CcSEcCtD
Levocabastine—Dry mouth—Docetaxel—lung cancer	0.00177	0.00282	CcSEcCtD
Levocabastine—Fatigue—Paclitaxel—lung cancer	0.00176	0.00281	CcSEcCtD
Levocabastine—Asthenia—Gemcitabine—lung cancer	0.00175	0.00279	CcSEcCtD
Levocabastine—Pain—Paclitaxel—lung cancer	0.00175	0.00278	CcSEcCtD
Levocabastine—Pharyngitis—Methotrexate—lung cancer	0.00174	0.00278	CcSEcCtD
Levocabastine—Visual impairment—Methotrexate—lung cancer	0.00169	0.0027	CcSEcCtD
Levocabastine—Asthenia—Cisplatin—lung cancer	0.00163	0.0026	CcSEcCtD
Levocabastine—Rash—Irinotecan—lung cancer	0.00158	0.00252	CcSEcCtD
Levocabastine—Dermatitis—Irinotecan—lung cancer	0.00158	0.00252	CcSEcCtD
Levocabastine—Headache—Irinotecan—lung cancer	0.00157	0.0025	CcSEcCtD
Levocabastine—Dyspnoea—Docetaxel—lung cancer	0.00154	0.00246	CcSEcCtD
Levocabastine—Somnolence—Docetaxel—lung cancer	0.00154	0.00245	CcSEcCtD
Levocabastine—Rash—Gemcitabine—lung cancer	0.00154	0.00245	CcSEcCtD
Levocabastine—Dermatitis—Gemcitabine—lung cancer	0.00154	0.00245	CcSEcCtD
Levocabastine—Erythema—Methotrexate—lung cancer	0.00153	0.00244	CcSEcCtD
Levocabastine—Headache—Gemcitabine—lung cancer	0.00153	0.00244	CcSEcCtD
Levocabastine—Pharyngitis—Doxorubicin—lung cancer	0.00151	0.00241	CcSEcCtD
Levocabastine—Asthenia—Etoposide—lung cancer	0.00149	0.00238	CcSEcCtD
Levocabastine—Fatigue—Docetaxel—lung cancer	0.00149	0.00238	CcSEcCtD
Levocabastine—Nausea—Irinotecan—lung cancer	0.00149	0.00237	CcSEcCtD
Levocabastine—Pain—Docetaxel—lung cancer	0.00148	0.00236	CcSEcCtD
Levocabastine—Visual impairment—Doxorubicin—lung cancer	0.00147	0.00234	CcSEcCtD
Levocabastine—Asthenia—Paclitaxel—lung cancer	0.00147	0.00234	CcSEcCtD
Levocabastine—Nausea—Gemcitabine—lung cancer	0.00145	0.00231	CcSEcCtD
Levocabastine—Rash—Cisplatin—lung cancer	0.00143	0.00229	CcSEcCtD
Levocabastine—Dermatitis—Cisplatin—lung cancer	0.00143	0.00228	CcSEcCtD
Levocabastine—Nausea—Cisplatin—lung cancer	0.00135	0.00215	CcSEcCtD
Levocabastine—Cough—Methotrexate—lung cancer	0.00133	0.00213	CcSEcCtD
Levocabastine—Erythema—Doxorubicin—lung cancer	0.00132	0.00211	CcSEcCtD
Levocabastine—Rash—Etoposide—lung cancer	0.00131	0.00209	CcSEcCtD
Levocabastine—Dermatitis—Etoposide—lung cancer	0.00131	0.00209	CcSEcCtD
Levocabastine—Headache—Etoposide—lung cancer	0.00131	0.00208	CcSEcCtD
Levocabastine—Rash—Paclitaxel—lung cancer	0.00129	0.00205	CcSEcCtD
Levocabastine—Dermatitis—Paclitaxel—lung cancer	0.00129	0.00205	CcSEcCtD
Levocabastine—Headache—Paclitaxel—lung cancer	0.00128	0.00204	CcSEcCtD
Levocabastine—Asthenia—Docetaxel—lung cancer	0.00124	0.00198	CcSEcCtD
Levocabastine—Nausea—Etoposide—lung cancer	0.00124	0.00197	CcSEcCtD
Levocabastine—Nausea—Paclitaxel—lung cancer	0.00121	0.00193	CcSEcCtD
Levocabastine—Cough—Doxorubicin—lung cancer	0.00116	0.00184	CcSEcCtD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	0.00115	0.00308	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—PIK3CD—lung cancer	0.00112	0.003	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—VEGFC—lung cancer	0.00112	0.003	CbGpPWpGaD
Levocabastine—Dyspnoea—Methotrexate—lung cancer	0.00111	0.00177	CcSEcCtD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—OXTR—lung cancer	0.00111	0.00298	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—lung cancer	0.00111	0.00298	CbGpPWpGaD
Levocabastine—Somnolence—Methotrexate—lung cancer	0.00111	0.00177	CcSEcCtD
Levocabastine—Dry mouth—Doxorubicin—lung cancer	0.0011	0.00176	CcSEcCtD
Levocabastine—Rash—Docetaxel—lung cancer	0.00109	0.00174	CcSEcCtD
Levocabastine—Dermatitis—Docetaxel—lung cancer	0.00109	0.00174	CcSEcCtD
Levocabastine—Headache—Docetaxel—lung cancer	0.00108	0.00173	CcSEcCtD
Levocabastine—Fatigue—Methotrexate—lung cancer	0.00108	0.00172	CcSEcCtD
Levocabastine—Pain—Methotrexate—lung cancer	0.00107	0.0017	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—ADCY1—lung cancer	0.00105	0.00283	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNG11—lung cancer	0.00104	0.00279	CbGpPWpGaD
Levocabastine—Nausea—Docetaxel—lung cancer	0.00103	0.00164	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—PPP2R1B—lung cancer	0.00103	0.00276	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—SMARCA4—lung cancer	0.00103	0.00276	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HSPB1—lung cancer	0.000992	0.00266	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PTHLH—lung cancer	0.00098	0.00263	CbGpPWpGaD
Levocabastine—Dyspnoea—Doxorubicin—lung cancer	0.000963	0.00154	CcSEcCtD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—OXTR—lung cancer	0.000961	0.00258	CbGpPWpGaD
Levocabastine—Somnolence—Doxorubicin—lung cancer	0.000961	0.00153	CcSEcCtD
Levocabastine—Fatigue—Doxorubicin—lung cancer	0.000932	0.00149	CcSEcCtD
Levocabastine—Pain—Doxorubicin—lung cancer	0.000924	0.00147	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—ANXA1—lung cancer	0.000922	0.00247	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—ANXA1—lung cancer	0.000914	0.00245	CbGpPWpGaD
Levocabastine—Asthenia—Methotrexate—lung cancer	0.000895	0.00143	CcSEcCtD
Levocabastine—HRH1—GPCR ligand binding—GIPR—lung cancer	0.000895	0.0024	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—FLT1—lung cancer	0.000893	0.0024	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—PIK3CG—lung cancer	0.000884	0.00237	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—APP—lung cancer	0.000874	0.00235	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NOTCH3—lung cancer	0.000874	0.00235	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—APP—lung cancer	0.000867	0.00233	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—FGF9—lung cancer	0.000867	0.00233	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—POMC—lung cancer	0.000842	0.00226	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—JUNB—lung cancer	0.000828	0.00222	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—OXTR—lung cancer	0.000823	0.00221	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—GRP—lung cancer	0.000823	0.00221	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—lung cancer	0.000818	0.00219	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PIK3CG—lung cancer	0.000803	0.00216	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—EP300—lung cancer	0.000803	0.00215	CbGpPWpGaD
Levocabastine—Rash—Methotrexate—lung cancer	0.000787	0.00125	CcSEcCtD
Levocabastine—Dermatitis—Methotrexate—lung cancer	0.000786	0.00125	CcSEcCtD
Levocabastine—Headache—Methotrexate—lung cancer	0.000782	0.00125	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—PIK3CD—lung cancer	0.000777	0.00209	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—APP—lung cancer	0.000775	0.00208	CbGpPWpGaD
Levocabastine—Asthenia—Doxorubicin—lung cancer	0.000775	0.00124	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—POMC—lung cancer	0.000764	0.00205	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—GRM8—lung cancer	0.000761	0.00204	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—STAT3—lung cancer	0.000753	0.00202	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—STK11—lung cancer	0.000751	0.00202	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL6R—lung cancer	0.000746	0.002	CbGpPWpGaD
Levocabastine—Nausea—Methotrexate—lung cancer	0.000741	0.00118	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—FOXO3—lung cancer	0.000725	0.00195	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—MAPK3—lung cancer	0.000719	0.00193	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—MAP2K1—lung cancer	0.000711	0.00191	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PIK3CD—lung cancer	0.000706	0.00189	CbGpPWpGaD
Levocabastine—Rash—Doxorubicin—lung cancer	0.000681	0.00109	CcSEcCtD
Levocabastine—Dermatitis—Doxorubicin—lung cancer	0.000681	0.00109	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—AVP—lung cancer	0.00068	0.00182	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—PIK3CB—lung cancer	0.000678	0.00182	CbGpPWpGaD
Levocabastine—Headache—Doxorubicin—lung cancer	0.000677	0.00108	CcSEcCtD
Levocabastine—HRH1—G alpha (q) signalling events—AVP—lung cancer	0.000674	0.00181	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IGF1R—lung cancer	0.000654	0.00176	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CXCL8—lung cancer	0.000651	0.00175	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HES1—lung cancer	0.000643	0.00172	CbGpPWpGaD
Levocabastine—Nausea—Doxorubicin—lung cancer	0.000642	0.00102	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—RAF1—lung cancer	0.00063	0.00169	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—GRP—lung cancer	0.000627	0.00168	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—OXTR—lung cancer	0.000627	0.00168	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—IL2—lung cancer	0.000622	0.00167	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PIK3CB—lung cancer	0.000615	0.00165	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—ANXA1—lung cancer	0.000606	0.00163	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—lung cancer	0.000603	0.00162	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—PIK3CA—lung cancer	0.000594	0.00159	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CXCL8—lung cancer	0.000591	0.00159	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—ERBB3—lung cancer	0.000588	0.00158	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—GNG11—lung cancer	0.000587	0.00157	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—APP—lung cancer	0.000574	0.00154	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL2—lung cancer	0.000565	0.00152	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TERT—lung cancer	0.000563	0.00151	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—FGFR1—lung cancer	0.000547	0.00147	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HIF1A—lung cancer	0.000539	0.00145	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—APOA1—lung cancer	0.00052	0.00139	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—KDR—lung cancer	0.000515	0.00138	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—GIPR—lung cancer	0.000506	0.00136	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—PTHLH—lung cancer	0.000491	0.00132	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—AKT1—lung cancer	0.000485	0.0013	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—KIT—lung cancer	0.000474	0.00127	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CG—lung cancer	0.000474	0.00127	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—APC—lung cancer	0.000474	0.00127	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—NRAS—lung cancer	0.000474	0.00127	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—EGF—lung cancer	0.000469	0.00126	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—ANXA1—lung cancer	0.000461	0.00124	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—GIPR—lung cancer	0.000459	0.00123	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—MAPK3—lung cancer	0.000454	0.00122	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—POMC—lung cancer	0.000452	0.00121	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	0.000446	0.0012	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—BRAF—lung cancer	0.000446	0.0012	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL6R—lung cancer	0.000441	0.00118	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CREBBP—lung cancer	0.00044	0.00118	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—APP—lung cancer	0.000437	0.00117	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—EGFR—lung cancer	0.000432	0.00116	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—GRM8—lung cancer	0.00043	0.00115	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MAP2K1—lung cancer	0.00042	0.00113	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CD—lung cancer	0.000417	0.00112	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—PIK3CA—lung cancer	0.000413	0.00111	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—KRAS—lung cancer	0.000408	0.0011	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—lung cancer	0.000391	0.00105	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—GRM8—lung cancer	0.000391	0.00105	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PIK3CA—lung cancer	0.000375	0.00101	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MDM2—lung cancer	0.000374	0.001	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—lung cancer	0.000373	0.001	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—RAF1—lung cancer	0.000372	0.000999	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—ERBB2—lung cancer	0.000368	0.000989	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CB—lung cancer	0.000364	0.000976	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MTOR—lung cancer	0.000364	0.000976	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—AXL—lung cancer	0.000358	0.000961	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—OXTR—lung cancer	0.000354	0.000951	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—GRP—lung cancer	0.000354	0.000951	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CXCL8—lung cancer	0.000349	0.000937	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—HRAS—lung cancer	0.000347	0.000931	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—AVP—lung cancer	0.00034	0.000912	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—AKT1—lung cancer	0.000337	0.000906	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CASP3—lung cancer	0.000334	0.000897	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL2—lung cancer	0.000334	0.000896	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL6—lung cancer	0.000332	0.000891	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—GNG11—lung cancer	0.000332	0.00089	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—lung cancer	0.00033	0.000887	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCND1—lung cancer	0.000325	0.000873	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—JUN—lung cancer	0.000325	0.000872	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—OXTR—lung cancer	0.000322	0.000863	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—GRP—lung cancer	0.000322	0.000863	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MMP9—lung cancer	0.000316	0.000848	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CDKN1A—lung cancer	0.000315	0.000845	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PTEN—lung cancer	0.000314	0.000843	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—AKT1—lung cancer	0.000306	0.000822	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—GNG11—lung cancer	0.000301	0.000808	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—EP300—lung cancer	0.0003	0.000804	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—ADCY1—lung cancer	0.000298	0.0008	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.000297	0.000796	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—SRC—lung cancer	0.000291	0.000782	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—VEGFA—lung cancer	0.000284	0.000761	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—STAT3—lung cancer	0.000281	0.000754	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NRAS—lung cancer	0.00028	0.000752	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—COL4A2—lung cancer	0.000279	0.000747	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PTHLH—lung cancer	0.000277	0.000744	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GIPR—lung cancer	0.000271	0.000728	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—ADCY1—lung cancer	0.000271	0.000727	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MAPK3—lung cancer	0.000268	0.00072	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PPP2R1B—lung cancer	0.000264	0.000708	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MYC—lung cancer	0.000261	0.000701	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—ANXA1—lung cancer	0.000261	0.000699	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—EGFR—lung cancer	0.000255	0.000685	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SDC4—lung cancer	0.000253	0.00068	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PTHLH—lung cancer	0.000252	0.000676	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	0.000249	0.000667	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—DUSP3—lung cancer	0.000248	0.000666	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—APP—lung cancer	0.000247	0.000663	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—RHEB—lung cancer	0.000243	0.000653	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—KRAS—lung cancer	0.000241	0.000647	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	0.000238	0.000639	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—ANXA1—lung cancer	0.000237	0.000635	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GRM8—lung cancer	0.000231	0.000619	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.00023	0.000616	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	0.000227	0.000608	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—POMC—lung cancer	0.000226	0.000606	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—APP—lung cancer	0.000224	0.000602	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SKI—lung cancer	0.000224	0.0006	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CA—lung cancer	0.000222	0.000595	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—PIK3CA—lung cancer	0.00022	0.00059	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TP53—lung cancer	0.000214	0.000575	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	0.000214	0.000574	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HRAS—lung cancer	0.000205	0.00055	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	0.000197	0.000528	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL6—lung cancer	0.000196	0.000527	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PXN—lung cancer	0.000194	0.000521	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—AVP—lung cancer	0.000192	0.000516	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GRP—lung cancer	0.00019	0.00051	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—AKR1C1—lung cancer	0.00019	0.00051	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—OXTR—lung cancer	0.00019	0.00051	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	0.000182	0.000488	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—AKT1—lung cancer	0.000181	0.000486	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GNG11—lung cancer	0.000178	0.000477	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCL8—lung cancer	0.000175	0.000469	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—AVP—lung cancer	0.000174	0.000468	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	0.000174	0.000467	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—VEGFC—lung cancer	0.000169	0.000455	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ADCY1—lung cancer	0.00016	0.000429	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SMARCA4—lung cancer	0.000156	0.000418	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PPP2R1B—lung cancer	0.000156	0.000418	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HSPB1—lung cancer	0.00015	0.000404	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTHLH—lung cancer	0.000149	0.000399	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ANXA1—lung cancer	0.00014	0.000375	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FLT1—lung cancer	0.000135	0.000363	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CG—lung cancer	0.000134	0.00036	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—APP—lung cancer	0.000133	0.000356	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NOTCH3—lung cancer	0.000133	0.000356	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FGF9—lung cancer	0.000131	0.000353	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—POMC—lung cancer	0.000128	0.000343	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—JUNB—lung cancer	0.000126	0.000337	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CG—lung cancer	0.000122	0.000327	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CD—lung cancer	0.000118	0.000316	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—POMC—lung cancer	0.000116	0.000311	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—STK11—lung cancer	0.000114	0.000306	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL6R—lung cancer	0.000113	0.000304	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FOXO3—lung cancer	0.00011	0.000295	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—MAP2K1—lung cancer	0.000108	0.000289	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CD—lung cancer	0.000107	0.000287	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—AVP—lung cancer	0.000103	0.000277	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CB—lung cancer	0.000103	0.000276	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IGF1R—lung cancer	9.92e-05	0.000266	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCL8—lung cancer	9.88e-05	0.000265	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HES1—lung cancer	9.75e-05	0.000262	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—RAF1—lung cancer	9.56e-05	0.000257	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—IL2—lung cancer	9.44e-05	0.000253	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CB—lung cancer	9.33e-05	0.00025	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCL8—lung cancer	8.97e-05	0.000241	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ERBB3—lung cancer	8.91e-05	0.000239	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL2—lung cancer	8.57e-05	0.00023	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TERT—lung cancer	8.54e-05	0.000229	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FGFR1—lung cancer	8.29e-05	0.000223	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HIF1A—lung cancer	8.17e-05	0.000219	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—APOA1—lung cancer	7.88e-05	0.000212	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—KDR—lung cancer	7.81e-05	0.00021	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—APC—lung cancer	7.2e-05	0.000193	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CG—lung cancer	7.2e-05	0.000193	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—KIT—lung cancer	7.2e-05	0.000193	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—NRAS—lung cancer	7.2e-05	0.000193	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—EGF—lung cancer	7.11e-05	0.000191	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—MAPK3—lung cancer	6.89e-05	0.000185	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—POMC—lung cancer	6.85e-05	0.000184	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—BRAF—lung cancer	6.76e-05	0.000182	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL6R—lung cancer	6.68e-05	0.000179	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CREBBP—lung cancer	6.67e-05	0.000179	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—EGFR—lung cancer	6.56e-05	0.000176	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MAP2K1—lung cancer	6.37e-05	0.000171	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CD—lung cancer	6.33e-05	0.00017	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	6.27e-05	0.000168	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—KRAS—lung cancer	6.19e-05	0.000166	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	5.69e-05	0.000153	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MDM2—lung cancer	5.67e-05	0.000152	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—RAF1—lung cancer	5.65e-05	0.000152	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ERBB2—lung cancer	5.59e-05	0.00015	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MTOR—lung cancer	5.51e-05	0.000148	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CB—lung cancer	5.51e-05	0.000148	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCL8—lung cancer	5.3e-05	0.000142	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—HRAS—lung cancer	5.26e-05	0.000141	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—AKT1—lung cancer	5.12e-05	0.000137	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CASP3—lung cancer	5.07e-05	0.000136	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL2—lung cancer	5.06e-05	0.000136	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL6—lung cancer	5.04e-05	0.000135	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCND1—lung cancer	4.94e-05	0.000132	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—JUN—lung cancer	4.93e-05	0.000132	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MMP9—lung cancer	4.79e-05	0.000129	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CDKN1A—lung cancer	4.78e-05	0.000128	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTEN—lung cancer	4.76e-05	0.000128	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—AKT1—lung cancer	4.65e-05	0.000125	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—EP300—lung cancer	4.54e-05	0.000122	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SRC—lung cancer	4.42e-05	0.000119	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—VEGFA—lung cancer	4.3e-05	0.000115	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—STAT3—lung cancer	4.26e-05	0.000114	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NRAS—lung cancer	4.25e-05	0.000114	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MAPK3—lung cancer	4.07e-05	0.000109	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MYC—lung cancer	3.96e-05	0.000106	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—EGFR—lung cancer	3.87e-05	0.000104	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—KRAS—lung cancer	3.66e-05	9.82e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CA—lung cancer	3.36e-05	9.02e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TP53—lung cancer	3.25e-05	8.73e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HRAS—lung cancer	3.11e-05	8.35e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL6—lung cancer	2.98e-05	7.99e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—AKT1—lung cancer	2.75e-05	7.37e-05	CbGpPWpGaD
